Cancer Treatment

·         06B082 - Dendroaspis natriuretic peptide - a treatment of cancer

·         06A049 - Urodilatin - A Treatment of Cancer

·         05A064 – Drug delivery by carbon nanotube-chitosan nanocomplexes

·         05A030 - A method of transdermal drug delivery using hyaluronic acid nanoparticles (ANP for melanoma)

·         05A026 - A Novel Gene Product Which Inhibits the Activity of NF-KB

·         04B099 - Nitroplatinum (IV) complexes for targeted anti-cancer therapy

·         04A009 - Method for treatment of lung cancer

·         04A002 - Palmerolides for cancer treatment

·         03B062 - New Combination Therapy for Treatment of Acute Myeloid Leukemia

·         03A036 - OCT-1: A novel oncoprotein

·         03A014 - Novel tumor of Stat3 for anti-cancer therapy

·         03A003 - New green tea-derived compounds for anti-cancer therapy

·         02B086 - Novel Anti Cancer Vaccine: Inhibition of Tumor Stat3 Expression

·         02B056/2B079 - Histone Deacetylase Inhibitors: New Combination Therapies for Anti Cancer Treatment

·         02A035 – Tumor classification software for diagnosis and treatment of tumors

·         02A027 – Differentially expressed gene therapy for the early detection of LGL leukemia

·         02A033 - New anti-cancer proteasome inhibitors: Organic copper compounds

·         Mice lacking interferon regulatory factor-1- Summary
    02A010- Mouse model suitable for treatment testing for lymphoma (ALCL) associated
   with AIDS, Hodgkin's disease and cutaneous T-cell lymphoma

·         01A032 - N-Thiolated β-lactams for use in anti-cancer therapy

·         01A025 - Farnesylamine Derivatives for Treatment of Cancer

·         01A016 – New cancer therapy: siRNA inhibition of lrba to suppress tumor growth

·         01A004 - Proliferated Cell Lines and Uses Thereof

·         00B053 - SHIP: A new protein target for allogeneic bone marrow transplants

·         00B051 - Stat3 Modulators to Induce or Suppress Stat3 Modulators to Induce or Suppress the Immune Response to Disease

·         00A025 – New targeted anti-cancer therapy using novel tea compounds

·         00A019 – RhoB as a suppressor of cancer cell growth and transformation

·         00A018 – Bax fragment with potent anti-cancer activity

·         00A016 – Anti-cancer vaccine: GM-CSF/CD40 ligand gene modified tumor cells

·         00A004 - MPCs: A new effective treatment for transplantation

·         99B057 - Anti-tumor and Anti-angiogenic Growth Factor Binding Molecules

·         99A007 - Mutated Src Oncogene for Use in Anti-Cancer Drug Discovery

·         98B047 – STAT3: An attractive protein target for prevention and treatment of cancer

Cancer Diagnosis

·         06A051 - Computer-Aided Pathological Diagnosis System

·         05B108 - Detection of ovarian cancer by elevated urinary levels of Bcl-2

·         02B077 - Imaging technique and software for creating 3D views of the breast

·         02B076 - Computer program for diagnosis of mammographic calcifications

·         02A035 – Tumor classification software for diagnosis and treatment of tumors

·         02A027 – Differentially expressed gene therapy for the early detection of LGL leukemia

·         02A023 - New Distinct Protein Profile for Lung Cancer Screening

·         01B079 – Method and system for the computerized assessment of breast cancer risk

·         99B052 – Bax degradation involvement in tumor survival and progression

Main menu 8